Budesonide for maintenance of remission in Crohn's disease

Overview of attention for article published in Cochrane database of systematic reviews, August 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
Good Attention Score compared to outputs of the same age and source (65th percentile)

Mentioned by

twitter: 18 tweeters

wikipedia: 6 Wikipedia pages

Citations

dimensions_citation: 70 Dimensions

Readers on

mendeley: 227 Mendeley

Summary Twitter Wikipedia Dimensions citations

So far, Altmetric has seen 19 tweets from 18 users, with an upper bound of 54,557 followers.

RT @gilkaplan: @CochraneLibrary publication by my PhD student @ekuenzig, led by @ericbenchimol on entocort for #crohns http://t.co/q4KqGjWi…

Reply Retweet Favourite

@CochraneLibrary publication by my PhD student @ekuenzig, led by @ericbenchimol on entocort for #crohns http://t.co/q4KqGjWiga

Reply Retweet Favourite

New pub from the CHEO IBD Centre: Budesonide for maintenance of remission in Crohn's disease, The Cochrane Library http://t.co/wV7IRVfWSk

Reply Retweet Favourite

#EII - Budesonida no es útil para el mantenimiento en enfermedad de #Crohn http://t.co/PTyqYwwdb5 #PubMed

Reply Retweet Favourite

#EII - Budesonida no es útil para el mantenimiento en enfermedad de #Crohn http://t.co/PTyqYwwdb5 #PubMed

Reply Retweet Favourite

#EII - Budesonida no es útil para el mantenimiento en enfermedad de #Crohn http://t.co/PTyqYwwdb5 #PubMed

Reply Retweet Favourite

Budesonide is not effective for maintenance of remission in CD, particularly beyond three months. http://t.co/CdRTv9iIYB

Reply Retweet Favourite

Budesonide for maintenance of remission in Crohn's disease. http://t.co/CdRTv9iIYB

Reply Retweet Favourite

Budesonide may not a good choice to maintain remission beyond 3 months in CD . Cochrane review #ibd conclusion http://t.co/1cnDchB5RL

Reply Retweet Favourite

Budesonide may not a good choice to maintain remission beyond 3 months in CD . Cochrane review #ibd conclusion http://t.co/1cnDchB5RL

Reply Retweet Favourite

Budesonide may not a good choice to maintain remission beyond 3 months in CD . Cochrane review #ibd conclusion http://t.co/1cnDchB5RL

Reply Retweet Favourite

(Cochrane) Budesonida no es eficaz como tto de mantenimiento en la enfermedad de Crohn http://t.co/JSG2M66UxR

Reply Retweet Favourite

(Cochrane) Budesonida no es eficaz como tto de mantenimiento en la enfermedad de Crohn http://t.co/JSG2M66UxR

Reply Retweet Favourite

(Cochrane) Budesonida no es eficaz como tto de mantenimiento en la enfermedad de Crohn http://t.co/JSG2M66UxR

Reply Retweet Favourite

(Cochrane) Budesonida no es eficaz como tto de mantenimiento en la enfermedad de Crohn http://t.co/JSG2M66UxR

Reply Retweet Favourite

(Cochrane) Budesonida no es eficaz como tto de mantenimiento en la enfermedad de Crohn http://t.co/JSG2M66UxR

Reply Retweet Favourite

(Cochrane) Budesonida no es eficaz como tto de mantenimiento en la enfermedad de Crohn http://t.co/JSG2M66UxR

Reply Retweet Favourite

(Cochrane) Budesonida no es eficaz como tto de mantenimiento en la enfermedad de Crohn http://t.co/JSG2M66UxR

Reply Retweet Favourite

More acne stories: Budesonide for maintenance of remission in Crohn's disease. http://t.co/0maMUq50R3

Reply Retweet Favourite